Navigation Links
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
Date:5/8/2013

arch 31, 2013 and December 31, 2012; noshares issued and outstanding atMarch 31, 2013 and December 31, 2012--Common stock, $.001 par value, 300,000,000shares authorized at March 31, 2013 andDecember 31, 2012 and;92,641,567 and 84,413,670 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively

9384Additional paid-in capital 

514,678512,174Accumulated other comprehensive income (loss)

1315Accumulated deficit

(456,172)(436,804)Total stockholders' equity 

58,61275,469Total liabilities and stockholders' equity 

$
,738$
39,154 

 

 

Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts)(Unaudited)Three Months Ended March 31, 20132012Revenues:Collaborative agreement $

857$

857License revenue 00Total revenues 857857Operating expenses:Research and development 15,1556,800General and administrative 5,1004,512Total operating expenses 20,25511,312Loss from operations (19,398)(10,455)Other income (expense):Interest income 3143Interest expense and other(1)(2)Total other income (expense) 3041Net loss $

(19,368)$

(10,414)Net loss per share - basic and diluted $

(0.21)$

(0.16)Shares used in computing net loss per share – basic and diluted 90,33665,989 

 


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Orexigen Therapeutics to Present at Upcoming Conferences
2. Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
3. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
6. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
7. Fate Therapeutics Strengthens Its iPSC Platform
8. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
9. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
10. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
11. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:12/25/2014)... The report “Service Quality Management and Telco Customer Experience ... Global Advancements, Worldwide Forecasts & Analysis (2014-2019)” defines and ... of revenues. , Browse 152 market data tables, ... on “Service Quality Management (SQM) and Telco Customer Experience ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... - Phase II PC-DAC(TM):Exendin-4 Data in December - ... MONTREAL, Nov. 5 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies,Inc. (TSX:CJB) ... Phase II,clinical trial of PC-DAC(TM):Exendin-4. This Phase II ... that,evaluated the efficacy and safety of three months ...
... Expands Contract Agreements to Include Specialty Pumps, ... Inc. (B. Braun),announced today it has signed a ... services company, to provide,specialty infusion pumps to Novation,s ... Novation develops and manages contracts with more ...
... CAMBRIDGE, Mass., Nov. 5 Verenium Corporation,(Nasdaq: ... next-generation cellulosic,ethanol and high-performance specialty enzymes, announced today ... will speak at the upcoming,Credit Suisse Alternative Energy ... and the future of transportation. The panel is ...
Cached Biology Technology:ConjuChem Provides Development Update 2ConjuChem Provides Development Update 3B. Braun Technology Wins Novation Specialty Infusion Pumps Contract Award 2B. Braun Technology Wins Novation Specialty Infusion Pumps Contract Award 3Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference 2Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference 3
(Date:1/22/2015)... Washington , January 20, 2015 Investorideas.com, ... tech stocks, releases video from the CES 2015 (Consumer Electronics ... Apollo Robbins . Apollo shows how easily ... smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Global Wearable Technologies ... Growth, Share, Overview, Trends and Forecast 2014-2020" ... Wearable Technologies are smart devices that can be ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014  Since its launch in ... of people to eliminate the pain of trying to remember ... their own biometrics fused to their smartphones. To assist people ... Labs , the company that created 1U and focuses on ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... MANHATTAN, KSDo those who know more also ... student,s confidence level correlate to academic performance? These ... of decisionmaking and education to study confidence. New ... looked at the psychological constructs of "confidence" and ...
... release is available in French . ... of Montreal,s Centre for Excellence in Pervasive Development Disorders ... brain resources in the areas associated with visual detection ... areas used to plan and control thoughts and actions. ...
... doses similar to those found in most nicotine replacements therapies ... according to results of a mouse study presented at the ... "If you take our data and combine it with epidemiological ... maintain the use of nicotine replacement therapy for months or ...
Cached Biology News:Student confidence correlated with academic performance 2Student confidence correlated with academic performance 3New research explains autistic's exceptional visual abilities 2Nicotine does not promote lung cancer growth in mouse models 2
Alexa Fluor 647 anti-mouse Qa-2...
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: